학술논문
Minimal Residual Disease After Autologous Stem-Cell Transplant for Patients With Myeloma: Prognostic Significance and the Impact of Lenalidomide Maintenance and Molecular Risk.
Document Type
Article
Author
Source
Journal of Clinical Oncology; 9/1/2022, Vol. 40 Issue 25, p2889-2900, 12p
Subject
Language
ISSN
0732183X